Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

DORAVIRINE vs DOSTARLIMAB: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

DORAVIRINE vs DOSTARLIMAB: Safety Overview

Metric DORAVIRINE DOSTARLIMAB
Total FAERS Reports 442 893
Deaths Reported 50 130
Death Rate 11.3% 14.6%
Hospitalizations 94 441
Average Patient Age 55.7 yrs 65.8 yrs
% Female Patients 23.1% 91.6%
FDA Approval Date Aug 30, 2018 N/A
Manufacturer Merck Sharp & Dohme LLC GlaxoSmithKline LLC
Route ORAL INTRAVENOUS
Marketing Status Prescription N/A